Ovarian function and gastrointestinal motor activity

Minerva Endocrinologica

Volumn 36, Issue 4, 2011, Pages 295-310

  Palomba, S ^a   Di Cello, A ^a   Riccio, E ^b   Manguso, F ^b   La Sala, G B ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

Estrogens; Gastrointestinal diseases; Gastrointestinal motility; Pregnancy

Indexed keywords

SEX HORMONE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; BILIARY TRACT DISEASE; BLOATING; CLIMACTERIUM; CONSTIPATION; DIARRHEA; GALLBLADDER DISEASE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; HUMAN; IRRITABLE COLON; LUTEAL PHASE; MENOPAUSE; NAUSEA; OVARIECTOMY; OVARY FUNCTION; PREGNANCY; PREVALENCE; REVIEW; SATIETY; SYMPTOM; VISCERAL PAIN; VOMITING;

AMYGDALA; ANIMALS; COMBINED MODALITY THERAPY; CONTRACEPTIVES, ORAL, HORMONAL; DISEASE SUSCEPTIBILITY; EMOTIONS; ESOPHAGEAL MOTILITY DISORDERS; ESTRADIOL; FEMALE; GALLBLADDER DISEASES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL HORMONES; GASTROINTESTINAL MOTILITY; GONADAL STEROID HORMONES; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MENSTRUAL CYCLE; OVARY; PREGNANCY; PREGNANCY COMPLICATIONS; RATS; SEX DISTRIBUTION; VISCERAL PAIN;

EID: 84858724376     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Bainbridge ET, Nicholas SD, Newton JR, Temple JG. Gastroesophageal reflux in pregnancy. Altered function of the barrier to reflux in asymptomatic women during early pregnancy. Scand J Gastroenterol 1985;19:85-9. (Pubitemid 14184772)
2. Knight LC, Parkman HP, Brown KL, Miller MA, Trate DM, Maurer AH et al. Delayed gastric emptying and decreased antral contractility in normal premenopausal women compared with men. Am J Gastroenterol 1997;92:968-75. (Pubitemid 27237587)
3. Pines A, Eckstein N, Dotan I, Ayalon D, Varon D, Barnea O et al. Effect of estradiol on rat ileum. Gen Pharmacol. 1998;31:735-6. (Pubitemid 28520050)
4. Hould FS, Fried GM, Fazekas AG, Tremblay S, Mersereau WA. Progesterone receptors regulate gallbladder motility. J Surg Res 1988;45:505-12. (Pubitemid 19005207)
5. Lock G, Kammerl M, Schlottmann K, Bregenzer N, Holstege A, Schölmerich J. Ggallbladder motility in healthy volunteers: Effects of age, gender, body mass index, and hair color. J Hepatogastroenterol 2003;50:1232-5. (Pubitemid 37186453)
6. Karamanolis G, Caenepeel P, Arts J, Tack J. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006;130:296-303. (Pubitemid 43202029)
7. El-Serag HB, Petersen NJ, Carter J, Graham DY, Richardson P, Genta RM et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 2004;126:1692-9. (Pubitemid 38736334)
8. Klauser A, Schindlbeck N, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335:205-8. (Pubitemid 20054587)
9. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003;290:66-72. (Pubitemid 37432867)
10. Van Thiel DH, Gavaler JS, Stremple J. Lower esophageal sphincter pressure in women using sequential oral contraceptives. Gastroenterology 1976;71:232-4.
11. Fisher R, Roberts G, Grabowski C, Cohen S. Altered lower esophageal sphincter function during early pregnancy. Gastroenterology 1978;74:1233-7. (Pubitemid 8352849)
12. Fisher R, Roberts G, Grabowski C, Cohen S. Inhibition of lower esophageal sphincter circular muscle by female sex hormones. Am J Physiol 1978;234:E243-47. (Pubitemid 9159840)
13. Jacobson BC, Moy B, Colditz GA, Fuchs CS. Postmenopausal hormone use and symptoms of gastroesophageal reflux. Arch Intern Med 2008 8;168:1798-804.
14. Aytuǧ N, Giral A, Imeryüz N, Enç FY, Bekiroǧlu N, Aktaş G et al. Gender influence on jejunal migrating motor complex. Am J Physiol Gastrointest Liver Physiol 2001;280:255-63.
15. Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology 2002;122:1701-14. (Pubitemid 34533563)
16. Chang L, Heitkemper M. Gender differences in irritable bowel syndrome. Gastroenterology 2002;123:1686-701. (Pubitemid 35231668)
17. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology 1997;112:2120-37. (Pubitemid 27240803)
18. Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser AS, Klapp BF et al. Somatic comorbidities of irritable bowel syndrome: A systematic analysis. J Psychosom Res 2008;64:573-82.
19. Heitkemper M, Jarrett M, Bond EF, Chang L. Impact of sex and gender on irritable bowel syndrome. Biol Res Nurs 2003;5:56-65.
20. Crowell MD, Dubin NH, Robinson JC, Cheskin LJ, Schuster MM, Heller BR et al. Functional bowel disorders in women with dysmenorrhea. Am J Gastroenterol 1994;89:1973-7. (Pubitemid 24334235)
21. Li TJ, Yu BP, Dong WG, Luo HS, Xu L, Li MQ. Ovarian hormone modulates 5-hydroxytryptamine 3 receptors mRNA expression in rat colon with restraint stress-induced bowel dysfunction. World J Gastroenterol 2004;10:2723-6. (Pubitemid 39214510)
22. Houghton LA, Brown H, Atkinson W, Morris J, Fell C, Whorwell PJ et al. 5-hydroxytryptamine signalling in irritable bowel syndrome with diarrhoea: effects of gender and menstrual status. Aliment Pharmacol Ther 2009;30:919-29.
23. Ji Y, Tang B, Traub RJ: The visceromotor response to the colorectal distension fluctuates with the estrous cycle in rats. Neuroscience 2008;154:1562-7.
24. Aloisi AM, Affaitati G, Ceccarelli I, Fiorenzani P, Lerza R, Rossi C et al. Estradiol and testosterone differently affect visceral pain-related behavioural responses in male and female rats. Eur J Pain 2010;14:602-7.
25. Kern F Jr, Everson GT. Contraceptive steroids increase cholesterol in bile: mechanisms of action. J Lip Res 1987;28:828-39.
26. Barbara L, Sama C, Labate AMM, Taroni F, Rusticali AG, Festi D et al. A population study on the prevalence of gallstone disease: the Sermione study. Hepatology 1987;7:913-7. (Pubitemid 17139241)
27. Yap L, Wycherley AG, Morphett AD, Toouli J. Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy. Gastroenterology 1991;101:786-93.
28. Sherman S, Troiano FP, Hawes RH, O'Connor KW, Lehman GA. Sphincter of Oddi manometry in patients with possible sphincter of Oddi dysfunction. Am J Gastroenterol 1991;86:586-90.
29. Boston Collaborative Drug Surveillance Program. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Lancet 1973;1:1399-404.
30. Friedman GD, Kannel WB, Dawber TR. The epidemiology of gallbladder disease: observations in the Framingham study. J Chron Dis 1966;19:273-92.
31. Singletary BK, Van Thiel DH, Eagon PK. Estrogen and progesterone receptors in human gallbladder. Hepatology 1986;6:574-8. (Pubitemid 16038171)
32. Wang HH, Liu M, Clegg DJ, Portincasa P, Wang DQ. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta 2009;1791:11:1037-47.
33. Braverman DZ, Johnson ML, Kern F Jr. Effects of pregnancy and contraceptive steroids on gallbladder function. N Engl J Med 1980;302:362-4. (Pubitemid 10166811)
34. Massa JS, Blask DE. Depressed prolactin cell activity in long-term blind-pinealectomized female hamsters is due to loss of estrous cyclicity. Proc Soc Exp Biol Med 1990;195:119-22. (Pubitemid 20337254)
35. Davies M, Ryan J. Influence of progesterone on guinea pig gallbladder motility in vitro. Dig Dis Sci 1986;31:513-8. (Pubitemid 16085576)
36. Shaffer EA, Taylor PJ, Logan K, Gadomski S, Corenblum B. The effect of a progestin on gallbladder function in young women. Am J Obstet Gynecol 1984;148:504-7. (Pubitemid 14196258)
37. Tierney S, Nakeeb A, Wong O, Lipsett PA, Sostre S, Pitt HA, Lillemoe KD. Progesterone alters biliary flow dynamics. Ann Surg 1999;229:205-9. (Pubitemid 30191793)
38. Kakar F, Weiss N, Strite S. Non-contraceptive estrogen use and the risk of gallstone disease in women. Am J Public Health 1988;78:564-6.
39. Grodstein F, Colditz GA, Stampfer MJ. Postmenopausal hormone use and cholecystectomy in a large prospective study. Obstet Gynecol 1994;83:5-11. (Pubitemid 24027372)
40. Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:58-66. (Pubitemid 34705519)
41. Ducker TE, Boss JW, Altug SA, Mehrabian H, Dekeratry DR, Clench MH et al. Luteinizing hormone and human chorionic gonadotropin fragment the migrating myoelectric complex in rat small intestine. Neurogastroenterol Motil 1996;8:95-100. (Pubitemid 26179342)
42. Chen TS, Doong ML, Chang FY, Lee SD, Wang PS. Effects of sex steroid hormones on gastric emptying and gastrointestinal transit in rats. Am J Physiol 1995;268:171-6.
43. Bruce LA, Beshudi FM. Increased gastrointestinal motility in vitro following chronic estrogen treatment in male rats. Proc Soc Exp Biol Med 1981;166:355-9. (Pubitemid 11110275)
44. Diaz M, Ramirez CM, Marin R, Marrero-Alonso J, Gomez T, Alonso R. Acute relaxation of mouse duodenum by estrogens. Evidence for an estrogen receptorindependent modulation of muscle excitability. Eur J Pharmacol 2004;501:161-78. (Pubitemid 39298949)
45. Heinemann A, Pieber D, Holzer P. Inhibition by female sex steroids of peristalsis in the guinea pig small intestine. Digestion 2002;65:213-9.
46. Doong ML, Lu CC, Kau MM, Tsai SC, Chiao YC, Chen JJ et al. Inhibition of gastric emptying and intestinal transit by amphetamine through a mechanism involving an increased secretion of CCK in male rats. Br J Pharmacol 1998;124:1123-30.
47. Yallampalli C, Kondapaka SB, Lanlua P, Wimalawansa SJ, Gangula PR. Female sex steroid hormones and pregnancy regulate receptors for calcitonin gene-related peptide in rat mesenteric arteries, but not in aorta. Biol Reprod 2004;70:1055-62. (Pubitemid 38387716)
48. Yang X, Liu R, Dong Y. Regulative effects of ovarian steroids on rat gastric motility and sensitivity. Sheng U Xue Bao 2006;58:275-80.
49. Wang J, Al-Chaer ED. Sex hormones modulate primary afferent responses to colorectal distension (CRD) in rats. Soc Neurosci Abst. 2007;725.
50. Ji Y, Murphy AZ, Traub RJ. Estrogen modulates the visceromotor reflex and responses of spinal dorsal horn neurons to colorectal stimulation in the rat. J Neurosci 2003;23:3908-15. (Pubitemid 36958496)
51. Ji Y, Tang B, Traub RJ. Modulatory effects of estrogen and progesterone on colorectal hyperalgesia in the rat. Pain 2005;117:433-42. (Pubitemid 41383538)
52. Ji Y, Murphy AZ, Traub RJ. Estrogen modulation of morphine analgesia of visceral pain in female rats is supraspinally and peripherally mediated. J Pain 2007;8:494-502. (Pubitemid 46843682)
53. Lazovic J, Wrzos HF, Yang QX, Collins CM, Smith MB, Norgren R et al. Regional activation in the rat brain during visceral stimulation detected by c-fos expression and fMRI. Neurogastroenterol Motil 2005;17:548-56. (Pubitemid 41075997)
54. Chrousos GP, Kino T, Charmandari E. Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence. Neuroimmunomodulation 2009;16:272-83.
55. Mönnikes H, Rüter J, König M, Grote C, Kobelt P, Klapp BF et al. Differential induction of c-fos expression in brain nuclei by noxious and non-noxious colonic distension: role of afferent C-fibers and 5-HT3 receptors. Brain Res 2003;966:253-64. (Pubitemid 36255588)
56. Altman G, Cain KC, Motzer S, Jarrett M, Burr R, Heitkemper M. Increased symptoms in female IBS patients with dysmenorrhea and PMS. Gastroenterol Nurs 2006;29:4-11.
57. Baron T, Ramirez B, Richter J. Gastrointestinal motility disorders in pregnancy. Ann Int Med 1993;118:366-75.
58. Everson G. Gastrointestinal motility in pregnancy. Gastroenterol Clin N Am 1992;21:751-6.
59. Koch K. Gastrointestinal factors in nausea and vomiting of pregnancy. Am J Obstet Gynecol 2002;186:198-203.
60. Ali RA, Egan LJ. Gastroesophageal reflux disease in pregnancy. Best Pract Res Clin Gastroenterol 2007;21:793-806. (Pubitemid 47413168)
61. Gill SK, Maltepe C, Koren G. The effect of heartburn and acid reflux on the severity of nausea and vomiting of pregnancy. Can J Gastroenterol 2009;23:270-2.
62. Tosetti C, Bellentani S, Benedetto E, Ubaldi E, Cardin F, Bozzani A; DyGeP Investigators and Researchers. The management of patients with new onset of upper gastro-intestinal symptoms in primary care. Dig Liver Dis 2010;42:860-4.
63. Infantino M. The prevalence and pattern of gastroesophageal reflux symptoms in perimenopausal and menopausal women. J Am Acad Nurse Pract 2008;20:266-72.
64. Zijdenbos IL, de Wit NJ, van der Heijden GJ, Rubin G, Quartero AO. Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009;1:CD006442.
65. Sanger GJ, Lee K. Hormones of the gut-brain axis as targets for the treatment of upper gastrointestinal disorders. Nat Rev Drug Discov 2008;7:241-54. (Pubitemid 351321235)
66. Hunt RH, Tougas G. Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments. Best Pract Res Clin Gastroenterol 2002;16:869-83.
67. Mathias JR, Ferguson KL, Clench MH. Debilitating "functional" bowel disease controlled by leuprolide acetate, gonadotropin-releasing hormone (GnRH) analog. Dig Dis Sci 1989;34:761-6. (Pubitemid 19139362)
68. Mathias JR, Clench MH, Abell TL, Koch KL, Lehman G, Robinson M et al. Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: A double-blind, placebo-controlled, randomized study. Dig Dis Sci 1998:43;1347-55. (Pubitemid 28272574)
69. Khanna R, Browne RM, Heiner AD, Clench MH, Mathias JR. Leuprolide acetate affects intestinal motility in female rats before and after ovariectomy. Am J Physiol 1992;262:G185-90.
70. Mathias JR, Clench MH, Reeves-Darby VG, Fox LM, Hsu PH, Roberts PH et al. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease: A double-blind, placebo-controlled study. Dig Dis Sci 1994;6:1155-62. (Pubitemid 24190250)
71. McGuinness B, Logan JI. Milk alkali syndrome. Ulster Med J 2002;71:132-5. (Pubitemid 36002274)
72. Mahadevan U, Kane S. American Gastroenterological Association Institute medical position statement on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006;131:278-82. (Pubitemid 44015758)
73. Mahadevan U. Gastrointestinal medications in pregnancy. Best Pract Res Clin Gastroenterol 2007;21:849-77. (Pubitemid 47413173)
74. Gordon MV, McMahon LP, Hamblin PS. Life-threatening milk-alkali syndrome resulting from antacid ingestion during pregnancy. Med J Aust 2005;182:350-1. (Pubitemid 40514934)
75. Nava-Ocampo AA, Valázquez-Armenta EY, Han JY, Koren G. Use of proton pump inhibitors during pregnancy and breastfeeding. Can Fam Physician 2006;52:853-4. (Pubitemid 44406032)
76. Richter J. The management of heartburn in pregnancy. Aliment Pharmacol Ther 2005;22:749-57.
77. West L, Warren J, Cutts T. Diagnosis and management of irritable bowel syndrome, constipation, and diarrhea in pregnancy. Gastroenterol Clin North Am 1992;21:793-802.
78. Creasy R, Resnik R, Iams JD, Lockwood CJ, Moore TR. Maternal fetal medicine principles and practice. 6th ed. Philadelphia, PA: WB Saunders; 2008.
79. Camilleri M, Mayer EA, Drossman DA, Heath A, Dukes GE, McSorley D, Kong S et al. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 antagonist. Aliment Pharmacol Ther 1999;13:1149-59. (Pubitemid 29445893)
80. Koch KM, Palmer JL, Noordin N, Tomlinson JJ, Baidoo C. Sex and age differences in the pharmacokinetics of alosetron. Br J Clin Pharmacol 2002;53:238-42. (Pubitemid 34226966)
81. Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1998;12:849-55. (Pubitemid 28428949)
82. Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE et al. Serotonin transporter polymorphism pharmacogenetics in diarrheapredominant irritable bowel syndrome. Gastroenterology 2002;123:425-32.
83. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxietyrelated traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-31. (Pubitemid 26403928)
84. Mizuno T, Aoki M, Shimada Y, Inoue M, Nakaya K, Takahashi T et al. Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. J Psychosom Res 2006;60:91-7. (Pubitemid 43003658)
85. Nakai A, Diksic M, Kumakura Y, D'Souza D, Kersey K. The effects of the 5-HT3 antagonist, alosetron, on brain serotonin synthesis in patients with irritable bowel syndrome. Neurogastroenterol Motil 2005;17:212-1.
86. Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005;17:863-70. (Pubitemid 41748282)
87. Degen L, Petrig C, Studer D, Schroller S, Beglinger C. Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil 2005;17:821-6. (Pubitemid 41746520)
88. Camilleri M. Review article: Tegaserod. Aliment Pharmacol Ther 2001;15:277-89. (Pubitemid 32187551)
89. Kaiser J. Gender in the pharmacy: Does it matter? Science 2005;308:1572-4. (Pubitemid 40807492)
90. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-51. (Pubitemid 40585355)
91. Verdú EF, Bercík P, Bergonzelli GE, Huang XX, Blennerhasset P, Rochat F et al. Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology 2004;127:826-37. (Pubitemid 39208415)